Sema4 is a rapidly growing patient-centered health intelligence company founded on the idea that more information, deeper analysis, and increased engagement will improve the diagnosis, treatment, and prevention of disease. Sema4 is dedicated to transforming healthcare by building dynamic models of human health and defining optimal, individualized health trajectories, starting in the areas of reproductive health and oncology. Centrellis™, their innovative health intelligence platform, is enabling them to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. 

Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.

Biotechnology

Sema4

Katherine Stueland

Don Williams

Yvonne Scott

Kelly Erwin

Alan B. Copperman M.D., Facog

Sertac Kip

Melissa Wolkon

Kareem Saad

Krish Ghosh

Kevin Feeley

Jennifer Brendel

Matthew Davis

Gustavo Stolovitzky

Murali Mani

The board of directors at Sema4 has a history of experience in genetics, biomedical research, data interpretation, and publication. They have also been involved in management positions at various companies including Magenta Therapeutics, Foundation Medicine, and ArcherDX, Inc. In addition to their professional experience, the board members also have a variety of educational backgrounds including degrees in human molecular genetics, biology, economics, data science, and biomedical engineering.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at Sema4

Leadership Team

CEO and Executive Team